StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30219% above fair value
$245.72−0.31 (-0.13%)

Close on Nov 13, 2026Market cap $14.55BP/E –Yield –

Glaukos cash

Cash and short-term investments held at the end of each period.

Glaukos's cash was $162.33M at Sep 30, 2026. For fiscal 2025 it was $90.81M, down 47.9% from the year before. Over ten years it grew -0.0% a year on average. The highest annual figure on record is $423.50M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$90.81M-47.9%
FY2024Dec 31, 2024$174.36M+86.5%
FY2023Dec 31, 2023$93.47M-26.2%
FY2022Dec 31, 2022$126.60M-70.1%
FY2021Dec 31, 2021$423.50M+2.3%
FY2020Dec 31, 2020$413.90M+125.8%
FY2019Dec 31, 2019$183.30M+22.8%
FY2018Dec 31, 2018$149.30M+25.5%
FY2017Dec 31, 2017$119.00M+24.2%
FY2016Dec 31, 2016$95.80M+5.2%
FY2015Dec 31, 2015$91.10M+3854.0%
FY2014Dec 31, 2014$2.30M-65.8%
FY2013Dec 31, 2013$6.73M+288.5%
FY2012Dec 31, 2012$1.73M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$162.33M+59.0%
Q2 FY2026Jun 30, 2026$114.49M+9.4%
Q1 FY2026Mar 31, 2026$104.25M-12.4%
Q4 FY2025Dec 31, 2025$90.81M-47.9%
Q3 FY2025Sep 30, 2025$102.08M-2.7%
Q2 FY2025Jun 30, 2025$104.65M+43.7%
Q1 FY2025Mar 31, 2025$118.99M+146.1%
Q4 FY2024Dec 31, 2024$174.36M+86.5%
Q3 FY2024Sep 30, 2024$104.88M-8.6%
Q2 FY2024Jun 30, 2024$72.81M-27.7%
Q1 FY2024Mar 31, 2024$48.35M-42.1%
Q4 FY2023Dec 31, 2023$93.47M-26.2%
Q3 FY2023Sep 30, 2023$114.79M+1.5%
Q2 FY2023Jun 30, 2023$100.67M-9.9%
Q1 FY2023Mar 31, 2023$83.48M-27.8%
Q4 FY2022Dec 31, 2022$126.60M-70.1%
Q3 FY2022Sep 30, 2022$113.10M-7.7%
Q2 FY2022Jun 30, 2022$111.68M-12.6%
Q1 FY2022Mar 31, 2022$115.62M+9.0%
Q4 FY2021Dec 31, 2021$423.50M+2.3%
Q3 FY2021Sep 30, 2021$122.55M+35.7%
Q2 FY2021Jun 30, 2021$127.71M-53.8%
Q1 FY2021Mar 31, 2021$106.04M+68.5%
Q4 FY2020Dec 31, 2020$413.90M+125.8%
Q3 FY2020Sep 30, 2020$90.32M+86.6%
Q2 FY2020Jun 30, 2020$276.30M+465.7%
Q1 FY2020Mar 31, 2020$62.94M+48.1%
Q4 FY2019Dec 31, 2019$183.30M+22.8%
Q3 FY2019Sep 30, 2019$48.42M+29.9%
Q2 FY2019Jun 30, 2019$48.84M+95.8%
Q1 FY2019Mar 31, 2019$42.49M+172.6%
Q4 FY2018Dec 31, 2018$149.30M+25.5%
Q3 FY2018Sep 30, 2018$37.28M+93.0%
Q2 FY2018Jun 30, 2018$24.94M+86.5%
Q1 FY2018Mar 31, 2018$15.59M+80.2%
Q4 FY2017Dec 31, 2017$119.00M+24.2%
Q3 FY2017Sep 30, 2017$19.32M–
Q2 FY2017Jun 30, 2017$13.37M–
Q1 FY2017Mar 31, 2017$8.65M–
Q4 FY2016Dec 31, 2016$95.80M–

More Glaukos figures

See a number that looks wrong?